Position in NKTR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$977
-$6,130 QoQ
Shares Held
14
-93.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#227
of 239 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $201,859,483 across 149 Biotechnology names. NKTR ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,898 | $40,681,193 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,244 | $18,234,803 | |
| 3 | TECH |
BIO-TECHNE Corp
|
117,371 | $8,292,261 | |
| 4 | VCEL |
Vericel Corp
|
185,051 | $8,232,918 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
65,659 | $7,529,117 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
95,681 | $7,488,951 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
87,238 | $6,497,486 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
193,236 | $6,452,150 |
All Filings in NKTR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $977 | 14 | Shares | Defined | 2026-08-05 | |
| 2022-12-31 | $7,107 | 3,145 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $8,128 | 2,540 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $8,033 | 2,114 | Shares | Defined | 2022-08-04 | |
| 2021-09-30 | $4,615 | 257 | Shares | Defined | 2021-10-15 | |
| 2020-03-31 | $1,160 | 65 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||